In the realm of pharmaceutical research and development (R&D), the purity of chemical intermediates is not a mere detail; it is a fundamental determinant of success. For compounds like 1,1-Ethanediol, 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-, hydrochloride (1:1), identified by CAS 214353-17-0, achieving and maintaining a high purity level, typically 99%, is essential for its utility in creating advanced therapeutic agents.

This specific trifluoroacetophenone hydrochloride intermediate serves as a crucial building block in the synthesis pathways of several important pharmaceuticals. Its molecular structure, featuring a trifluoromethyl group and a chloro-substituted phenyl ring, contributes unique properties that can enhance a drug's pharmacokinetic profile, such as improved metabolic stability and membrane permeability. These attributes are highly valued by medicinal chemists seeking to optimize drug candidates for better efficacy and patient outcomes.

The R&D phase of drug development is characterized by extensive experimentation, iterative design, and rigorous testing. High-purity intermediates ensure that the observed experimental results are attributable to the intended compound, minimizing variables introduced by impurities. This is particularly vital when synthesizing complex molecules like Efavirenz, where this intermediate plays a direct role. Research scientists often search for terms like “high purity CAS 214353-17-0 for R&D” or “trifluoroacetophenone hydrochloride research grade,” indicating their need for materials that meet stringent laboratory standards. Sourcing from manufacturers who can guarantee this level of purity, such as NINGBO INNO PHARMCHEM CO.,LTD., is a strategic advantage.

Moreover, the cost-effectiveness of R&D is always a consideration. While high purity comes at a cost, using impure intermediates can lead to failed experiments, wasted resources, and delayed timelines. Therefore, investing in a reliable supply of 99% pure CAS 214353-17-0 from reputable manufacturers in China can ultimately save time and money in the long run. The ability to “buy” such intermediates with confidence, knowing they meet strict quality requirements, allows R&D teams to focus on innovation rather than troubleshooting material inconsistencies.

In essence, the 99% purity of trifluoroacetophenone hydrochloride is a cornerstone for reliable and efficient pharmaceutical R&D. It empowers scientists to explore new chemical frontiers, develop innovative drug candidates, and accelerate the journey from laboratory discovery to clinical application. For any organization involved in this critical field, partnering with a supplier committed to delivering high-purity intermediates is an indispensable strategy.